Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Board of Directors in DanCann Pharma A/S has resolved on a partially (77 percent) secured Rights Issue of approximately DKK 28.5 million and publishes prospectus

COPENHAGEN, Denmark, October 21, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announces that the Board of Directors in DanCann Pharma today has formally resolved on the previously announced partially (77 percent) guaranteed rights issue of units corresponding to a total of approximately DKK 28.5 million (the “Rights Issue”). The resolution was made based on the authorization from the Extraordinary General Meeting of the Company that was held on the September 20, 2022. The purpose of the Rights Issue is to secure

Polygiene Group invites you to a presentation of the third quarter 2022

Polygiene Group will publish its quarterly report for the third quarter (July-September) on October 27, 2022, at 8.00 CET. In connection to the announcement, Polygiene Group invites you to a video conference on the same day at 10.00 CET.· Presentation of the quarterly report, CEO Ulrika Björk · Review of the financial results, CFO Niklas Blomstedt The conference is expected to last 45 minutes and will be held in English. Registration is made via the link below no later than October 26, 2022. Instructions regarding access to the conference will be sent out via e-mail when you have

Amendment: Heliospectra (publ) Publish the Interim Report for July-September 2022

(GOTHENBURG, Sweden, Oct 21, 2022, at 11:25 CET)– Heliospectra AB (publ), a leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents its Interim Report for July-September 2022. The amendment regards order intake for the period July-Sep and the period Jan-Sep 2022.Full report is enclosed to this press release and is also uploaded at https://www.heliospectra.com/investor-relations/reports-documents-archive. SUMMARY OF REPORT SALES AND FINANCIAL PERFORMANCE JULY-SEPTEMBER · Order intake during the period July - September amounted to

AcouSort travels to Japan to re-ignite marketing efforts as the country opens up after the pandemic

AcouSort has been established on the Japanese market since 2019 when the company signed an exclusive distribution agreement with its Japanese partner Physio-Tech. The same year AcouSort also initiated a collaboration with a leading Japanese life science company. After almost three years of stringent restrictions, Japan has now opened up the country for overseas visitors. As one of the world’s largest healthcare markets, Japan is a prioritized market for AcouSort and a team of representatives will now travel east to re-ignite the marketing efforts.The AcouSort team will visit the company’s

Invitation to DNB's Capital Markets Day - 15 November 2022

DNB is pleased to invite you to the Group's Capital Markets Day. Date: Tuesday 15 November 2022Time: 12:00 pm - 2:00 pm GMT. Registration and lunch from 11:00 am - 12:00 pm GMT Location: DNB Bank ASA London Office, 8th Floor, The Walbrook Building, 25 Walbrook, London We will present an update on financial targets and strategic topics. In addition, our largest customer segments will provide a more detailed update. Speakers at the CMD will be:- Kjerstin R. Braathen, CEO- Ida Lerner, CFO- Harald Serck-Hanssen, Group EVP Corporate Banking- Ingjerd Blekeli Spiten, Group EVP

Nordic Iron Ore AB prolongs the short-term loan facilities

During 2021 and 2022 Nordic Iron Ore AB has taken up loan facilities of SEK 15.5 million from the Company's three largest owners Bengtssons Tidnings AB, Ludvika Holding AB and Kopparinvest AB as well as the company's board member Timo Lindborg via company. The motivation for the facilities was to provide working capital for evaluating of the Company's financing options. The evaluation on financing options as well as the negotiations with Cargill is progressing and therefore the facilities has now been extended by three months to run through March 2023. Summary of the terms of the loan

Nomination Committee and AGM 2023

The Nomination Committee of Projektengagemang Sweden AB (publ) has been appointed for the 2023 Annual General Meeting (AGM), which will be held on 4 May, 2023 in Stockholm.In accordance with the decided instruction for the appointment of a Nomination Committee in Projektengagemang, the Nomination Committee, which shall consist of four members with the Chairman of the Board Per-Arne Gustavsson as convener,  has been appointed before the 2023 AGM. Members of the Projektengagemang Nomination Committee are: • Per Göransson, appointed by Projektengagemang Holding AB, Heroine Holding AB and

Bittium Exhibits Its Products for Secure and Tactical Communication at the NATO Edge event in Belgium

Press release Free for publication on October 21, 2022, at 12.00 pm (CEST +1) Bittium Exhibits Its Products for Secure and Tactical Communication at the NATO Edge event in Belgium Oulu, Finland, October 21, 2022 – Bittium’s secure smartphones and solutions can be seen onsite at the NATO Edge event on 25 - 27 October 2022, in Mons, Belgium. On display at the Bittium stand B61 are Bittium Tough Mobile™ 2 smartphones, Bittium Secure Suite™ back-end system and smartphone accessories. Bittium experts also demonstrate the use of the secure Bittium Secure Call™ communication

BioStock: Chordate could contribute to migraine care in Sweden

Over 1 million Swedes suffer from migraine and the majority of them are women. Migraine care is considered to be inadequate and many are undiagnosed. In addition, today’s drugs are often associated with a decreasing treatment effect and side effects. Sweden’s new government wants to see a change and has thus decided to place greater emphasis on care for migraines and other women’s diseases, according to the recent Statement of Government Policy. Chordate Medical’s CEO Anders Weilandt says that they want to contribute to this with K.O.S, a drug-free and preventive migraine treatment.Read the

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 216 - 21 OCTOBER 2022  In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

BioStock: Evaxion brings in Per Norlén as CEO

With the recently initiated phase IIb trial in melanoma, Evaxion Biotech has entered a new, advanced clinical development phase with its portfolio of AI-driven immunotherapies. The company is ready to build a solid commercial profile and pursue strong partnerships to bring its products to market to help millions of cancer patients worldwide. A significant step in that direction was appointing industry veteran Per Norlén to the CEO position. BioStock reached out to the new CEO and Evaxion’s Chair of the Board, Marianne Soegaard, to learn more about this important transition for the company.

Nomination committee appointed ahead of 2023 Annual General Meeting of Fractal Gaming Group AB (publ)

In accordance with the decision of the Annual General Meeting (AGM), Fractal Gaming Group´s nomination committee shall consist of the three largest shareholders as of September 30 and the Chairman of the Board. Fractal Gaming Group hereby announces that the nomination committee has now been appointed ahead of the AGM 17 May, 2023. The nomination committee consists of the following members:Carl-Mikael Lindholm, appointed by Herenco HoldingLars Verneholt, appointed by Litorina IV L.P.Daniel Johnsson, appointed by Långholmen Holding ABMagnus Yngen, Chairman of the Board, Fractal

Calliditas Therapeutics’ nomination committee composition for the AGM 2023

Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2023.The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting in 2017, consists of: • Patrick Sobocki, appointed by Stiftelsen Industrifonden • Karl Tobieson, appointed by Linc AB • Jan Särlvik, appointed by Fjärde AP-fonden • Elmar Schnee (chairman of the board of directors) The nomination committee shall, before the annual general meeting 2023, prepare a proposal for the election of chairman and other members

Brighter’s warrants of series TO9 are admitted to trading

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. The rights issue of shares and warrants in Brighter AB (publ) (“Brighter” or the “Company”) was registered at the Swedish Companies Registration Office on October 17, 2022. The warrants of series TO9 will be trading on Nasdaq First North Growth Market, starting October 28, 2022, under the ticker “BRIG TO9” with ISIN-code SE0018537862. The

One RescueRunner system ordered to French Fire Rescue Services

We are very pleased to announce that another Fire Rescue Services department in France have ordered a RescueRunner system.Through our French distributor Fire Technologies Eurl, another Fire Rescue Service department in France order a RescueRunner system. The Fire Rescue Service department will primarily use the new RescueRunner for increased water rescue capacity in the event of floodings and on inland waters in the area. The RescueRunner system is a very flexible and efficient boat system that can operate in shallow and inaccessible waters and crucial for the Fire Rescue Service

BioStock: PHI expands market potential with regenerative medicine opportunity

Phase Holographic Imaging’s sales have doubled in one year, according to the company’s annual report published this week. However, it generates even more confidence for the company because PHI now addresses the entire spectrum of the healthcare market, not just medical research. The company aims to become a welded link in the value chain of modern medicine in general and regenerative medicine in particular. To find out more, BioStock contacted the company’s CFO, Patrik Eschricht.Read the interview with PHI's CFO Patrik Eschricht at biostock.se: PHI expands market potential with

Data show OXC-201 may be a promising treatment for allergic asthma.

A new study, Pharmacological OGG1 inhibition decreases murine allergic airway inflammation, was published 17[th] of October in Respiratory pharmacology, Frontiers in Pharmacology, (DOI 10.3389/fphar.2022.999180, Tanner L, Bergwik J, Bhongir RKV, Pan L, Dong C, Wallner O, Kalderén C, Helleday T, Boldogh I, Adner M and Egesten A) and demonstrates that Oxcia’s potential clinical candidate OXC-201 (TH5487) may be a promising treatment for allergic asthma.Allergic asthma is a complex inflammatory disease characterized by wheezing, dyspnea, coughing, chest tightness and variable airflow

Invitation to presentation of Humana's report on third quarter 2022

Humana's interim report for the third quarter and nine-month period 2022 results will be published at 08:00 CET on November 10, 2022. A web-cast telephone conference will be held at 09:00 CET the same day.The webcast, where CEO and President Johanna Rastad will present the report, will be accessible at Humana's website www.humanagroup.com. The presentation material will be published on the website before the conference starts. The webcast, and later the recorded version of the webcast, will also be available at www.financialhearings.com.  To participate in the conference call, and

Publishing of Stockmann’s Interim Management Statement for January–September 2022

STOCKMANN plc, Press release 21.10.2022 at 10:00 EET Stockmann plc will publish its Interim Management Statement for January–September 2022 on Friday, 28 October 2022 at 8:00 a.m. EET. A press and analyst briefing will be held in English the same day at 10:00 a.m. EET in the Stockmann Lounge on the 4A floor in Stockmann’s Helsinki city centre department store, entrance from the F staircase on the Pohjoisesplanadi side. The event can also be followed as a live webcast by this link . The recording and presentation material will be available on

Getinge to support the American Heart Association in progressing care for cardiogenic shock patients

Today, Getinge announces its support of the American Heart Association initiative to build a Cardiogenic Shock Registry. This unparalleled initiative will enable a wide range of cardiogenic shock research, based on patient data from hospitals across the US, and lead to opportunities to promote best practices and improve clinical outcomes. Historically, data related to cardiogenic shock has been limited, inconsistent, and challenging to interpret. If not treated quickly, cardiogenic shock can lead to organ failure and death. Even when treated timely and at specialized centers, the

BioStock: ClearPoint Neuro delivers first order to CLS

Following the FDA clearance of Clinical Laserthermia Systems’ MR-guided laser ablation system in neurosurgery, US commercialisation was swiftly initiated. The commercialisation is led by the medtech’s global distributor ClearPoint Neuro. On Monday, CLS could announce that their efforts have already paid off in the form of a first order worth 5,5 million SEK. BioStock reached out to CLS’ CEO Dan Mogren for a comment.Read the article at biostock.se: https://www.biostock.se/en/2022/10/clearpoint-neuro-delivers-first-order-to-cls/ This is a press release from BioStock - Connecting

Formpipe signs a multi-year agreement with the Danish Board of Agriculture to a business value of approximately DKK 80-100 million.

The Danish Board of Agriculture (Landbrugsstyrelsen) has carried out a procurement regarding continued operation and development of one of the agency's administrative systems. Formpipe has been chosen as the main supplier in a service agreement where Formpipe's responsibility includes development and system maintenance. The assignment is performed in collaboration with Capgemini as a subcontractor with responsibility for system support.The agreement runs over four years with options to extend with additional three years, and the order value amounts to a minimum of DKK  7 million in the form

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release October 21, 2022 at 9:50 a.m. Nokian Tyres has received an announcement from BlackRock, Inc. on October 20, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the indirect holding in Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below the level of 5% of the share capital of Nokian Tyres plc, as a result of share transactions concluded on October 19, 2022. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------+-----

There are no items matching the current filter
There are no more items matching the current filter
Back to top